Projektbeschreibung
Förderung der Forschung an Protein-Wirkstoff-Konjugaten
Im Institute of Molecular Medicine (IMM) in Portugal stehen in der Erforschung des menschlichen Genoms und der Entwicklung neuer therapeutischer Ansätze große Fortschritte bevor. Das EU-finanzierte Projekt SIMICA nimmt das IMM über ein dauerhaftes Wissenschafts-, Technologie- und Innovationsnetzwerk aus international führenden Organisationen für Protein-Wirkstoff-Konjugate in den europäischen Kreis der exzellenten Forschungseinrichtungen auf. Die Strategie von SIMICA basiert auf wissenschafts- sowie innovationsgetriebener Clusterbildung. Im Projekt geht es um Konzeption und Aufbau der neusten Generation chemisch definierter und innovativer Protein-Wirkstoff-Konjugate für die zielgenaue Behandlung ernsthafter Erkrankungen wie beispielsweise Krebs. Auch Schulungen und Mentorenbetreuung für die Nachwuchsforscherinnen und -forscher am IMM sind Teil des Vorhabens.
Ziel
SIMICA will provide IMM with the opportunity to integrate the European circle of research excellence institutions by cementing a sustainable science, technology and innovation network with internationally-leading organisations in the field of protein drug-conjugates. The strategy of SIMICA is based on science- and innovation-driven clustering, and is focused on the exciting and upcoming area of designing and constructing the next generation of chemically-defined and innovative protein drug-conjugates for the targeted treatment of serious conditions such as cancer. The project will allow: i) strengthening the science and technology capacity of IMM and ii) leverage its research excellence and value creation through innovation with a beneficial and quantifiable impact for the entire research and development community at IMM, the Lisbon region and Portugal. The successful implementation of this strategy will rely on specific actions, including: 1) cementing of existing and the creation of new scientific, innovative and technical collaborations through short-term staff exchanges and short-term on-site training activities; 2) training, mentoring and international exposure of IMMs young researchers and students; 3) building an innovation ecosystem centred at IMM; 4) igniting the entrepreneurial spirit among IMMs research community; 5) increasing science awareness among the general public through targeted dissemination and communication activities; and 6) developing a sustainability strategy to sustain the cemented network beyond project terminus. Through the completion of these activities, IMM, supported by its twinning partners, is in the best temporal and spatial position to achieve an improved capability to compete for internationally competitive research funding and to access business stakeholders. By claiming its position in research and innovation networks IMM will effectively contribute to research excellence and value creation in health at European level.
Schlüsselbegriffe
Programm/Programme
- H2020-EU.4.b. - Twinning of research institutions Main Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
(öffnet in neuem Fenster) H2020-WIDESPREAD-2018-2020
Andere Projekte für diesen Aufruf anzeigenUnterauftrag
H2020-WIDESPREAD-2018-03
Finanzierungsplan
CSA -Koordinator
1649-035 LISBOA
Portugal